If they have technically begun clinical trials, what phase are they
in? Once the human trials start in 2007, what phase will that be
considered. Also, are they on this so-called "fast track" with the
FDA? That seems to be either a catch phrase for hope or a real push
with the FDA to expedite what seems to more than promising. I/m pretty
sure that Dr. Vinik's work at the Strelitz institute is on the "fast
track." Any feeback would be welcome, thanks!